Identification and characterization of M6903, an antagonistic anti–TIM-3 monoclonal antibody-Reference-Cited by-同舟云学术

Identification and characterization of M6903, an antagonistic anti–TIM-3 monoclonal antibody

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zhang Dong¹^ORCID,Jiang Feng¹,Zaynagetdinov Rinat¹,Huang Hui¹,Sood Vanita D.²^ORCID,Wang Hong¹,Zhao Xinyan²,Jenkins Molly H.¹^ORCID,Ji Qingyong²,Wang Youbin²,Nannemann David P.²,Musil Djordje³,Wesolowski John²,Paoletti Andrea⁴,Bartholomew Tin¹,Derner Melissa G.¹,An Qi²,Iffland Christel²,Halle Joern-Peter¹⁵

Affiliation:

1. Department of Immuno-Oncology, EMD Serono Research and Development Institute, Billerica, MA, USA

2. Discovery and Development Technologies, EMD Serono Research and Development Institute, Billerica, MA, USA

3. Discovery and Development Technologies, Merck Healthcare KGaA, Darmstadt, Germany

4. Discovery and Development Technologies, Merck Healthcare KGaA, Colleretto Giacosa, Italy

5. Department of Immuno-Oncology, Merck Healthcare KGaA, Darmstadt, Germany

Funder

EMD Serono, a biopharmaceutical business of Merck KGaA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1744921

Reference43 articles.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of human serum concentration–time profiles of therapeutic monoclonal antibodies using common marmosets ( Callithrix jacchus ): initial assessment with canakinumab, adalimumab, and bevacizumab;Xenobiotica;2024-07-26

2. High-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistance;Communications Medicine;2024-07-02

3. Structure-Based Rational Design of Constrained Peptides as TIM-3 Inhibitors;ACS Medicinal Chemistry Letters;2024-05-28

4. Establishment of novel anti-TIM-3 antibodies interfering with its binding to ligands;Heliyon;2024-04

5. Discovery of lung adenocarcinoma tumor antigens and ferroptosis subtypes for developing mRNA vaccines;Scientific Reports;2024-02-08